TCOT
NVO

Trust Company of Toledo’s Novo Nordisk NVO Stock Holding History

Trust Company of Toledo’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6K Hold
700
– – ﹤0.01% 527
2026
Q1 		$25.7K Hold
700
– – ﹤0.01% 536
2025
Q4 		$35.6K Sell
700
-156
-18% -$7.98K ﹤0.01% 473
2025
Q3 		$47.5K Hold
856
– – ﹤0.01% 437
2025
Q2 		$59.1K Buy
+856
New +$58.2K 0.01% 390

Other funds holding NVO

EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

Trust Company of Toledo's NVO Position: Q2 2026 in Review

Trust Company of Toledo held its Novo Nordisk (NVO) position steady in Q2 2026 at 700 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #527.

Trust Company of Toledo first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $59.1K in Q2 2025. 623 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Trust Company of Toledo held 700 shares of Novo Nordisk worth $33.6K as of Q2 2026.
  • Trust Company of Toledo left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #527 holding.
  • Trust Company of Toledo first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
  • Trust Company of Toledo's Novo Nordisk position peaked at $59.1K in Q2 2025.
  • 623 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.